The Global Amniotic Membrane Market Size accounted for USD 3.1 Billion in 2021 and is projected to achieve a market size of USD 10.2 Billion by 2030 rising at a CAGR of 14.2% from 2022 to 2030. Increasing awareness among the people in the recent past has led to a surge in the number of transplants leading to rising demand for these tissue-based products. It has also led to increase in the number of donations thus, boosting market growth.
Amniotic Membrane Market Report Statistics
- Global amniotic membrane market revenue is estimated to reach USD 10.2 Billion by 2030 with a CAGR of 14.2% from 2022 to 2030
- North America amniotic membrane market share accounted for over 32% shares in 2021
- According to the Plastic Surgery Statistics Report 2020, there were 15.6 million cosmetic procedures performed
- Asia-Pacific amniotic membrane market growth will register swift CAGR from 2022 to 2030
- Based on enzyme, cryopreserved amniotic membrane acquired over 59% of the overall market share in 2021
- Among end-use, hospitals acquired over 40% market chunk in 2021
- Increasing demand for amniotic membrane in ophthalmic surgeries will fuel the global amniotic membrane market value
- Rising usage for amniotic eye treatment is a popular amniotic membrane market trend that is fueling the industry demand
Amniotic membrane has piqued the interest of healthcare providers and doctors due to its numerous benefits, including restoring epidermal function and integrating itself into the healing process, as well as acting as a skin substitute in wound care. Depending on the indication, amniotic membrane is used as a graft or patch in the treatment of eye diseases. Because of the disruptions in the supply chain caused by the COVID-19 outbreak, the market suffered. The market was hampered by a temporary halt in supply and manufacturing, which limited revenue generation. However, key players are launching a variety of initiatives to address the challenges faced by the COVID-19 lockdown.
Global Amniotic Membrane Market Dynamics
Market Drivers
- Growing in the target patient population
- Growth in the number of accident and trauma wounds
- Rising awareness towards benefits offered by amniotic membrane
Market Restraints
- Lack of standardized guidelines
- Shortage of skilled professionals
Market Opportunities
- Surging venture capital investments and government spending
- Increasing research on stem cell biology
Amniotic Membrane Market Report Coverage
Market |
Amniotic Membrane Market |
Amniotic Membrane Market Size 2021 |
USD 3.1 Billion |
Amniotic Membrane Market Forecast 2030 |
USD 10.2 Billion |
Amniotic Membrane Market CAGR During 2022 - 2030 |
14.2% |
Amniotic Membrane Market Analysis Period |
2018 - 2030 |
Amniotic Membrane Market Base Year |
2021 |
Amniotic Membrane Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Enzyme, By Application, By End-Use, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Amnio Technology, Alliqua BioMedical Inc., Applied Biologics LLC, Human Regenerative Technologies, Amniox Medical Inc., DermaSciences, Organogensis, Inc., Katena Products, Inc., Skye Biologics, Inc., and MiMedx Group Inc. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Amniotic Membrane Market Growth Factors
Increasing hazardous cases in trauma, burnt cases and leading to cure through surgeries, also increasing awareness highlighting the benefits of amniotic membrane based products are boosting the demand for the products driving the global amniotic membrane market. Increasing cases of cosmetic surgeries performed worldwide is also another factor likely to drive the growth of market during the forecast period. Amniotic membrane is also being utilized in the healing of a large number of ocular surface diseases as it protects surfaces from microbial colonization minimizing the risk of infections.
Amniotic Membrane Market Insights
Numerous NGOs such as American Association of Tissue Banks which regulates tissue donation in the U.S. Presence of similar tissue banks is to ensure zero infection transmission which leads to diseases, which, sequentially, accelerates market growth by increasing the demand. Moreover, a number of medical institutions are trying to bring in novel areas of application for these products by focusing on the research activities in regenerative medicines and applications of stem cell. This is among the other prime factors that are likely to maintain market expansion globally. Cryopreserved amniotic membrane is widely used in hospitals, ambulatory surgical centers (ASCs), and few other specialty clinics. Lyophilization of the tissue post donation conserve the biological and histological activity of the tissue facilitating faster wound recovery.
Amniotic Membrane Market Segmentation
The global amniotic membrane market is segmented based on enzyme, application, end-use, and geography.
Amniotic Membrane Market By Enzyme
- Cryopreserved Amniotic Membrane
- Dehydrated Amniotic Membrane
According to our amniotic membrane industry analysis, the cryopreserved amniotic membrane section was the significant revenue contributor in 2021 and is expected to continue this trend during the forecast period. The high share in the segment was credited to its high efficiency and adoption rates globally. This type of membrane is typically stored at -80°C in a cell culture medium containing 50% glycerol. The histological and biological properties of the amniotic membrane are well preserved in cryopreserved amniotic membranes.
Amniotic Membrane Market By Application
- Surgical Wounds
- Ophthalmology
- Others
According to our analysis, surgical wounds generated the largest revenue in 2021 and are expected to continue its trend during the forecast timeframe from 2022 to 2030. Because of the increasing prevalence of chronic and infectious diseases, there has been a global increase in the number of surgeries, boosting market potential.
Amniotic Membrane Market By End-Use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Research and Academic Institutes
According to our amniotic membrane market forecast, hospital segment would gain significant impetus from 2022 to 2030. This is mainly due to frequent visits by patients as hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. The increasing use of amniotic membranes in ASCs is anticipated to be another significant factor driving market growth in the coming years.
Amniotic Membrane Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Amniotic Membrane Market Regional Analysis
Among the regions, North America amniotic membrane market is a leading having the maximum share owing to presence of a large number of key companies and high incidence of infectious and chronic diseases. This region is expected to continue having the maximum market share during the forecast period. The Asia-Pacific amniotic membrane market is anticipated to record the highest CAGR during the forecast period owing to growing population and rising incidence of burn injuries and chronic diseases.
Amniotic Membrane Market Players
The key players catering to the global amniotic membrane market are Amnio Technology, Alliqua BioMedical Inc., Applied Biologics LLC, Human Regenerative Technologies, Amniox Medical Inc., DermaSciences, Organogensis, Inc., Katena Products, Inc., Skye Biologics, Inc., and MiMedx Group Inc. The global players are continuously investing in R&D activities and innovating to have updated product portfolio to attract more and more business opportunity from the emerging nation such as India and China. Further changing customers’ preferences are encouraging global players to develop innovative technology solution to cater best to the market. Also, Increasing R&D investments coupled with technological advancements to commercialize highly efficient products are anticipated to offer lucrative opportunities for industry participants.
CHAPTER 1. Industry Overview of Amniotic Membrane Market
1.1. Definition and Scope
1.1.1. Definition of Amniotic Membrane
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Amniotic Membrane Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Amniotic Membrane Market By Enzyme
1.2.3. Amniotic Membrane Market By Application
1.2.4. Amniotic Membrane Market By End-Use
1.2.5. Amniotic Membrane Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Amniotic Membrane Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Amniotic Membrane Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Amniotic Membrane Market By Enzyme
4.1. Introduction
4.2. Amniotic Membrane Revenue By Enzyme
4.2.1. Amniotic Membrane Revenue (USD Billion) and Forecast, By Enzyme, 2018-2030
4.2.2. Cryopreserved Amniotic Membrane
4.2.2.1. Cryopreserved Amniotic Membrane Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Dehydrated Amniotic Membrane
4.2.3.1. Dehydrated Amniotic Membrane Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Amniotic Membrane Market By Application
5.1. Introduction
5.2. Amniotic Membrane Revenue By Application
5.2.1. Amniotic Membrane Revenue (USD Billion) and Forecast, By Application, 2018-2030
5.2.2. Surgical Wounds
5.2.2.1. Surgical Wounds Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Ophthalmology
5.2.3.1. Ophthalmology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Others
5.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Amniotic Membrane Market By End-Use
6.1. Introduction
6.2. Amniotic Membrane Revenue By End-Use
6.2.1. Amniotic Membrane Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Ambulatory Settings
6.2.3.1. Ambulatory Settings Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Specialty Clinics
6.2.4.1. Specialty Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Research and Academic Institutes
6.2.5.1. Research and Academic Institutes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Amniotic Membrane Market By Country
7.1. North America Amniotic Membrane Market Overview
7.2. U.S.
7.2.1. U.S. Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
7.2.2. U.S. Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
7.2.3. U.S. Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
7.3.2. Canada Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
7.3.3. Canada Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Amniotic Membrane Market By Country
8.1. Europe Amniotic Membrane Market Overview
8.2. U.K.
8.2.1. U.K. Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.2.2. U.K. Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.2.3. U.K. Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.3.2. Germany Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.3.3. Germany Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.4.2. France Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.4.3. France Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.5.2. Spain Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.5.3. Spain Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
8.6.2. Rest of Europe Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
8.6.3. Rest of Europe Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Amniotic Membrane Market By Country
9.1. Asia Pacific Amniotic Membrane Market Overview
9.2. China
9.2.1. China Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.2.2. China Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.2.3. China Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.3.2. Japan Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3.3. Japan Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.4.2. India Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.4.3. India Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.5.2. Australia Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.5.3. Australia Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.6. South Korea
9.6.1. South Korea Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.6.2. South Korea Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.6.3. South Korea Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
9.7.2. Rest of Asia-Pacific Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
9.7.3. Rest of Asia-Pacific Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Amniotic Membrane Market By Country
10.1. Latin America Amniotic Membrane Market Overview
10.2. Brazil
10.2.1. Brazil Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
10.2.2. Brazil Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
10.2.3. Brazil Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
10.3.2. Mexico Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3.3. Mexico Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
10.4.2. Rest of Latin America Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4.3. Rest of Latin America Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Amniotic Membrane Market By Country
11.1. Middle East & Africa Amniotic Membrane Market Overview
11.2. GCC
11.2.1. GCC Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
11.2.2. GCC Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
11.2.3. GCC Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
11.3.2. South Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
11.3.3. South Africa Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Enzyme, 2018-2030
11.4.2. Rest of Middle East & Africa Amniotic Membrane Revenue (USD Billion) and Forecast By Application, 2018-2030
11.4.3. Rest of Middle East & Africa Amniotic Membrane Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Amniotic Membrane Market
12.1. Amniotic Membrane Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Amniotic Membrane Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Amnio Technology
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Amnio Technology 2021 Amniotic Membrane Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Alliqua BioMedical Inc.
13.3. Applied Biologics LLC
13.4. Katena Products
13.5. Human Regenerative Technologies
13.6. DermaSciences
13.7. Organogensis, Inc.
13.8. Katena Products, Inc.
13.9. Skye Biologics, Inc.
13.10. MiMedx Group Inc.